Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Depreciation & Amortization (CF) (2016 - 2025)

Nephros (NEPH) has 16 years of Depreciation & Amortization (CF) data on record, last reported at $12000.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) changed 0.0% year-over-year to $12000.0; the TTM value through Sep 2025 reached $54000.0, up 22.73%, while the annual FY2024 figure was $46000.0, 17.95% up from the prior year.
  • Depreciation & Amortization (CF) reached $12000.0 in Q3 2025 per NEPH's latest filing, down from $13000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $66000.0 in Q3 2022 and bottomed at $1000.0 in Q1 2023.
  • Average Depreciation & Amortization (CF) over 5 years is $12684.2, with a median of $11000.0 recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): plummeted 91.67% in 2023, then skyrocketed 1000.0% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $16000.0 in 2021, then plummeted by 31.25% to $11000.0 in 2022, then decreased by 9.09% to $10000.0 in 2023, then grew by 20.0% to $12000.0 in 2024, then changed by 0.0% to $12000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $12000.0 in Q3 2025, $13000.0 in Q2 2025, and $17000.0 in Q1 2025.